Raia Drogasil S.A. Sponsored ADR logo

Raia Drogasil S.A. Sponsored ADR (RADLY)

Market Closed
11 Aug, 20:00
OTC PINK OTC PINK
$
3. 59
-0.23
-6.0209%
$
6.68B Market Cap
49.21 P/E Ratio
0.04% Div Yield
500 Volume
0 Eps
$ 3.82
Previous Close
Add Transaction
Day Range
3.47 3.59
Year Range
3.07 5.34
Want to track RADLY and more in your Portfolio? 🎯
Sign up for Marketlog, a portfolio tracker that will exceed your expectations!

Summary

RADLY closed today lower at $3.59, a decrease of -6.0209% from yesterday's close, completing a monthly increase of 6.5282% or $0.22. Over the past 12 months, RADLY stock lost -19.5608%.
RADLY pays dividends to its shareholders, with the most recent payment made on Jan 08, 2026. The next announced payment will be in In 4 months on Dec 11, 2026 for a total of $0.017.
The last earnings report, released on May 12, 2026, missed the consensus estimates by -0.0343%. On average, the company has fell short of earnings expectations by -0.0196%, based on the last three reports.
Raia Drogasil S.A. Sponsored ADR has completed 3 stock splits, with the recent split occurring on Dec 24, 2025.
The company's stock is traded on one exchange.

RADLY Chart

People also search for

Bangkok Dusit Medical Services Public Company Limited Unsponsored ADR
$ 23.3
0%
Bangkok Dusit Medical Services Public Company Limited
$ 0.56
0%
Makita Corporation Sponsored ADR
$ 34.2
+0.411%
FNCL 2.5 2013 USB Float
$ 50,000
0%
Alibaba Health Information Technology Ltd.
$ 8.85
0%
Raia Drogasil S.A. (RADLY) Q2 2026 Earnings Call Transcript

Raia Drogasil S.A. (RADLY) Q2 2026 Earnings Call Transcript

Raia Drogasil S.A. (RADLY) Q2 2026 Earnings Call Transcript

Seekingalpha | 6 days ago
Raia Drogasil S.A. (RADLY) Q1 2026 Earnings Call Transcript

Raia Drogasil S.A. (RADLY) Q1 2026 Earnings Call Transcript

Raia Drogasil S.A. (RADLY) Q1 2026 Earnings Call Transcript

Seekingalpha | 3 months ago
Short Interest in Raia Drogasil S.A. (OTCMKTS:RADLY) Increases By 138.8%

Short Interest in Raia Drogasil S.A. (OTCMKTS:RADLY) Increases By 138.8%

Raia Drogasil S.A. (OTCMKTS:RADLY - Get Free Report) was the target of a significant increase in short interest in the month of February. As of February 27th, there was short interest totaling 8,015 shares, an increase of 138.8% from the February 12th total of 3,356 shares. Based on an average daily volume of 13,990 shares,

Defenseworld | 5 months ago

Raia Drogasil S.A. Sponsored ADR (RADLY) FAQ

What is the stock price today?

The current price is $3.59.

On which exchange is it traded?

Raia Drogasil S.A. Sponsored ADR is listed on OTC PINK.

What is its stock symbol?

The ticker symbol is RADLY.

Does it pay dividends? What is the current yield?

Yes, It pays dividends and the current yield is 0.04%.

What is its market cap?

As of today, the market cap is 6.68B.

Has Raia Drogasil S.A. Sponsored ADR ever had a stock split?

Raia Drogasil S.A. Sponsored ADR had 3 splits and the recent split was on Dec 24, 2025.

Raia Drogasil S.A. Sponsored ADR Profile

Pharmaceuticals Industry
Healthcare Sector
Renato Raduan CEO
OTC PINK Exchange
750723108 CUSIP
BR Country
73,895 Employees
13 Jul 2026 Last Dividend
24 Dec 2025 Last Split
- IPO Date

Overview

Raia Drogasil S.A. stands as a prominent entity in the Brazilian retail market, specializing in the distribution and sale of a broad spectrum of health and beauty products. Founded in 1905, the company has established a strong foothold in the industry, navigating through the evolving consumer needs and the dynamic pharmaceutical landscape in Brazil. As of March 31, 2022, Raia Drogasil S.A. boasts an extensive network, operating 2,530 drug stores across 26 Brazilian states. The company’s commitment to accessibility and customer satisfaction extends beyond brick-and-mortar outlets, utilizing telesales and leveraging three call centers strategically located in São Paulo, Tocantins, and Pernambuco to enhance its reach and service delivery. Headquartered in São Paulo, Brazil, Raia Drogasil S.A.'s enduring legacy and continuous growth underscore its pivotal role in the retail pharmacy sector, driven by a relentless pursuit of excellence and innovation in meeting the healthcare and beauty needs of its clientele.

Products and Services

  • Medicines

Raia Drogasil S.A. provides a comprehensive range of medicines, encompassing both prescription and over-the-counter (OTC) options to meet the healthcare needs of its customers. The company ensures a wide selection of pharmaceuticals to address various health concerns, from common ailments to chronic conditions, emphasizing quality and reliability.

  • Perfumery, Personal Care, and Beauty Products

Understanding the growing consumer demand for personal care and beauty products, Raia Drogasil S.A. offers an expansive assortment of items in these categories. From daily hygiene essentials to luxury beauty brands, the company caters to diverse preferences and budgets, ensuring its customers find everything they need for their personal care routines under one roof.

  • Cosmetics and Dermocosmetics

The company also delves into the specialized segment of cosmetics and dermocosmetics, providing products designed to meet the skincare needs of its clientele. Raia Drogasil S.A. curates a selection of high-quality brands known for their effectiveness and skincare benefits, addressing everything from basic skincare to specific dermatological concerns.

  • Specialty Medicines

Raia Drogasil S.A.’s catalog includes specialty medicines that cater to patients with specific and often complex medical conditions. These high-value pharmaceuticals require special handling, storage, and administration, underscoring the company’s commitment to offering comprehensive healthcare solutions that extend to specialized care needs.

  • Telesales and Call Centers

Beyond its physical retail presence, Raia Drogasil S.A. innovatively uses telesales and operates three call centers in São Paulo, Tocantins, and Pernambuco. These channels aim to augment the shopping experience, offering convenience to customers preferring to order their products remotely, ensuring timely delivery of medicines and products directly to their doorsteps. This service highlights the company’s adaptability and forward-thinking approach in catering to evolving customer preferences and the trend towards digital retailing within the pharmacy sector.

Contact Information

Address: Av. Corifeu de Azevedo Marques, 3097
Phone: 55 11 3769 5678